Ted St. Martin

Ted St. Martin, Chief Financial Officer, brings over 25 years of finance experience, including nearly 20 years in the life science industry at both commercial and clinical-stage companies. Prior to joining Mindera Health, Ted served as Vice President, Finance at Ventyx Biosciences, Inc., where he led all corporate finance and planning activities and played a key role in the company’s $162M Initial Public Offering in October 2021 and $160M Series A & B raises.

Previously, Ted was Chief Financial Officer at Dart Neuroscience, where he built a successful finance organization, supporting the company’s growth into late-stage clinical trials.  He held various senior financial roles in other companies such as Aries Pharmaceuticals, Phenomix Corporation, Ligand Pharmaceuticals, and Geneohm Sciences (acquired by Becton, Dickinson and Company).  Ted started his career in public accounting at Ernst & Young LLP. He is a licensed certified public accountant in California and received his B.S. in Accounting from Purdue University and M.B.A from San Diego State University.